In accordance to recent findings, caspase-2 promotes obesity, the metabolic syndrome and non-alcoholic fatty liver disease [35] and for that reason may become a potential target to correct obesity and its associated comorbidities. This evidence concerns the gene CASP2 and obesity due to melanocortin 4 receptor deficiency.